Declan Doogan, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 80,000 shares at $44.24 ($3.5M) on 2019-02-13, disclosed to the SEC on 2019-02-14.
Open-market sale of $3.5M BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.32 | 33,842 | $1.5M | 42.3% |
| 2 | $44.32 | 33,842 | $1.5M | 42.3% |
| 3 | $44.24 | 6,158 | $272K | 7.7% |
| 4 | $44.24 | 6,158 | $272K | 7.7% |
| Total | $44.31 avg | 80,000 | $3.5M | 100% |
| Filing → |
| BHVN | SELL | 2022-02-11 | $5.0M | — | Filing → |
| BHVN | SELL | 2021-12-01 | $5.5M | — | Filing → |
| BHVN | SELL | 2021-11-17 | $8.8M | — | Filing → |